Proton Pump Inhibitors, Dual Antiplatelet Therapy, and the Risk of Gastrointestinal Bleeding

被引：3
|
作者：
Marlicz, Wojciech [1 ]
Loniewski, Igor [2 ]
Koulaouzidis, George [2 ]
机构：
[1] Pomeranian Med Univ, Dept Gastroenterol, Unii Lubelskiej 1, PL-71252 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Biochem Sci, Szczecin, Poland
来源：
MAYO CLINIC PROCEEDINGS | 2022年 / 97卷 / 04期
关键词：
MYOCARDIAL-INFARCTION; ASSOCIATION; GUIDELINES; DISEASE;
D O I：
10.1016/j.mayocp.2022.02.023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：648 / 651
页数：4
相关论文
共 50 条
  • [41] Proton pump inhibitors therapy and the risk of hip fracture in older people in Taiwan
    Lai, Shih-Wei
    Lin, Chih-Hsueh
    Lin, Cheng-Li
    Liao, Kuan-Fu
    EUROPEAN GERIATRIC MEDICINE, 2018, 9 (02) : 169 - 174
  • [42] Previous hypertensive hemorrhage increases the risk for bleeding and ischemia for PCI patients on dual antiplatelet therapy
    Qiao, Manli
    Bi, Qi
    Fu, Paul
    Wang, Yixin
    Song, Zhe
    Guo, Fang
    NEUROLOGICAL RESEARCH, 2017, 39 (06) : 516 - 520
  • [43] Assessment of bleeding risk in patients with coronary artery disease on dual antiplatelet therapy A systematic review
    Vries, Minka J. A.
    van der Meijden, Paola E. J.
    Henskens, Yvonne M. C.
    ten Cate-Hoek, Arina J.
    ten Cate, Hugo
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (01) : 7 - 24
  • [44] Nonvitamin K oral anticoagulants with proton pump inhibitor cotherapy ameliorated the risk of upper gastrointestinal bleeding
    Chaiyana, Parata
    Techathuvanan, Karjpong
    Sethasine, Supatsri
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [45] Balancing Ischemic and Bleeding Risks of Prolonged Dual Antiplatelet Therapy
    Levine, Glenn N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (02): : 194 - 195
  • [46] Use of clopidogrel and proton pump inhibitors after a serious acute coronary event: Risk of coronary events and peptic ulcer bleeding
    Garcia Rodriguez, Luis A.
    Johansson, Saga
    Cea Soriano, Lucia
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (05) : 1014 - 1024
  • [47] Conflicting Results Between Randomized Trials and Observational Studies on the Impact of Proton Pump Inhibitors on Cardiovascular Events When Coadministered With Dual Antiplatelet Therapy Systematic Review
    Melloni, Chiara
    Washam, Jeffrey B.
    Jones, W. Schuyler
    Halim, Sharif A.
    Hasselblad, Victor
    Mayer, Stephanie B.
    Heidenfelder, Brooke L.
    Dolor, Rowena J.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (01): : 47 - U91
  • [48] Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization
    Marquis-Gravel, Guillaume
    Neely, Megan L.
    Valgimigli, Marco
    Costa, Francesco
    Van Klaveren, David
    Altner, Rituparna
    Bhatt, Deepak L.
    Armstrong, Paul W.
    Fox, Keith A. A.
    White, Harvey D.
    Ohman, E. Magnus
    Roe, Matthew T.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (09): : 627 - 638
  • [49] Comprehensive analysis of proton pump inhibitors and risk of digestive tract cancers
    Zeng, Ruijie
    Cheng, Yunjiu
    Luo, Dongling
    Wang, Jinghua
    Yang, Jun
    Jiang, Lei
    Zhuo, Zewei
    Guo, Kehang
    Wu, Huihuan
    Leung, Felix W.
    Sha, Weihong
    Chen, Hao
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : 190 - 201
  • [50] Correlation between proton pump inhibitors and risk of pyogenic liver abscess
    Lin, Hsien-Feng
    Liao, Kuan-Fu
    Chang, Ching-Mei
    Lin, Cheng-Li
    Lai, Shih-Wei
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (08) : 1019 - 1025
12345